Evidence map›Paper›PMID 26883276›Full record

ArticleGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society2016

Growth factors, aging and age-related diseases.

Priya Balasubramanian, Valter D Longo

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04807959 completednot on this map

A Retrospective Study to Evaluate the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program

TypeobservationalSponsor20LighterRan2016 to 2018Enrolled2,200ConditionsObesity, Obesity, Morbid, Obesity, Visceral, Central ObesityArms20Lighter anti-obesity program
NCT05219240 unknown statusnot on this mapstarted 2020, after this paper: background citation

Evaluation of Body Composition Improvement With Visceral Adiposity-Focused Anti-Obesity Telehealth Program

TypeobservationalSponsor20LighterRan2020 to 2024Enrolled2,000ConditionsObesity, Cardiovascular Diseases, Metabolic Syndrome, Metabolic DiseaseArms20Lighter Program
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Targeting macro- and micro-nutrient regulation of HNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  4. Review
  5. A synonymous mutation inMolecular therapy. Nucleic acids · 2021
    Article
  6. Review
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Priya BalasubramanianLongevity Institute, Davis School of Gerontology, University of Southern California, Los Angeles, California, United States.
Valter D LongoLongevity Institute, Davis School of Gerontology, University of Southern California, Los Angeles, California, United States; IFOM, FIRC Institute of Molecular Oncology, Milano, Italy. Electronic address: vlongo@usc.edu.
FIRC Institute of Molecular Oncology · ITUniversity of Southern California · US

Funding

The Role of the Glucose-regulated Protein GRP78/BiP in Stress Resistance and AginP01AG034906 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LONGO, VALTER D. · 2011 to 2016
$9.3M
Role of Longevity Regulatory Pathways in Age-dependent Macro-molecular Damage inR01AG020642 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LONGO, VALTER D. · 2003 to 2017
$4.8M
NIA NIH HHS P01 AG034906NIA NIH HHS R01 AG020642
6 · The paper itself

Abstract

Simple organisms including yeast and flies with mutations in the IGF-1 and Tor-S6K pathways are dwarfs, are highly protected from toxins, and survive up to 3 times longer. Similarly, dwarf mice with deficiencies in the growth hormone-IGF-I axis are also long lived and protected from diseases. We recently reported that humans with Growth Hormone Receptor Deficiency (GHRD) rarely develop cancer or diabetes. These findings are in agreement with the effect of defects in the Tor-S6K pathways in causing dwarfism and protection of DNA. Because protein restriction reduces both GHR-IGF-1 axis and Tor-S6K activity, we examined links between protein intake, disease, and mortality in over 6000 US subjects in the NHANES CDC database. Respondents aged 50-65 reporting a high protein intake displayed an increase in IGF-I levels, a 75% increased risk of overall mortality and a 3-4 fold increased risk of cancer mortality in agreement with findings in mouse experiments. These studies point to a conserved link between proteins and amino acids, GHR-IGF-1/insulin, Tor-S6k signaling, aging, and diseases.

Indexed as

AgingAnimalsCaloric RestrictionDiabetes MellitusDiet, Protein-RestrictedGrowth HormoneHumansInsulin-Like Growth Factor ILongevityNeoplasmsReceptors, SomatotropinRibosomal Protein S6 KinasesSignal TransductionTOR Serine-Threonine KinasesGrowth HormoneInsulin-Like Growth Factor IReceptors, SomatotropinRibosomal Protein S6 KinasesTOR Serine-Threonine KinasesAmino acidsCalorie restrictionGrowthGrowth hormoneGrowth hormone receptor deficiencyIGF-1ProteinsRasTOR

Identifiers

PMID26883276
PMCPMC5455771
OpenAlexW2232824718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.